Increases in B-type natriuretic peptide (BNP) during treatment with lenalidomide in AL amyloidosis.
Umit
U
Tapan
David C
DC
Seldin
Kathleen T
KT
Finn
Salli
S
Fennessey
Anthony
A
Shelton
Jerome B
JB
Zeldis
Vaishali
V
Sanchorawala
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000686:Amyloidosis / Q000188:drug therapy*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood*; D002986:Clinical Trials as Topic; D005260:Female; D006321:Heart / Q000187:drug effects; D006801:Humans; D000077269:Lenalidomide; D008297:Male; D008875:Middle Aged; D020097:Natriuretic Peptide, Brain / Q000097:blood* / Q000187:drug effects; D012189:Retrospective Studies; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D015415:Biomarkers; D020097:Natriuretic Peptide, Brain; D013792:Thalidomide; D000077269:Lenalidomide